Baupost Group - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 90 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Baupost Group ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$10,344,000
+8.3%
2,394,4980.0%0.12%
+36.0%
Q2 2019$9,554,000
-25.6%
2,394,4980.0%0.09%
-20.4%
Q1 2019$12,835,000
+4.5%
2,394,4980.0%0.11%
+0.9%
Q4 2018$12,284,000
-47.1%
2,394,4980.0%0.11%
-39.9%
Q3 2018$23,227,000
-4.9%
2,394,4980.0%0.18%
-16.8%
Q2 2018$24,424,000
-21.5%
2,394,4980.0%0.21%
-28.7%
Q1 2018$31,128,000
-27.4%
2,394,4980.0%0.30%
-29.2%
Q4 2017$42,862,000
-28.7%
2,394,4980.0%0.42%
-43.4%
Q3 2017$60,102,000
+4.2%
2,394,4980.0%0.75%
+13.7%
Q2 2017$57,707,000
+46.6%
2,394,498
+17.1%
0.66%
+42.3%
Q1 2017$39,357,000
+25.0%
2,044,4980.0%0.46%
+12.9%
Q4 2016$31,485,000
+18.4%
2,044,4980.0%0.41%
+8.5%
Q3 2016$26,599,000
-6.5%
2,044,4980.0%0.38%
-2.1%
Q2 2016$28,439,000
+21.4%
2,044,498
+32.4%
0.39%
+14.2%
Q1 2016$23,430,000
-20.0%
1,544,4980.0%0.34%
-36.3%
Q4 2015$29,299,000
-0.2%
1,544,4980.0%0.53%
+8.6%
Q3 2015$29,345,000
-26.3%
1,544,4980.0%0.49%
-26.2%
Q2 2015$39,802,000
-26.6%
1,544,498
-11.0%
0.66%
-27.2%
Q1 2015$54,243,000
-12.7%
1,735,2180.0%0.91%
-25.3%
Q4 2014$62,100,0001,735,2181.22%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders